October 9, 2013

A new law in Maine will allow consumers to purchase drugs by mail order from some pharmacies overseas, according to published reports.

October 8, 2013

A Republican congressman from Alabama has proposed a stopgap bill that would fund the Food and Drug Administration through the middle of December or until the government shutdown ends, though it is unlikely to pass in the Senate.

October 8, 2013

GreenLight Rx is offering a line of medicine bottles aimed at elderly people and those suffering from such conditions as arthritis, the company said.

October 8, 2013

Consumers paid more for prescriptions as the country's economy recovered from the recession, according to a new study.

October 7, 2013

The National Psoriasis Foundation and the Arthritis Foundation are presenting the country's first program specifically devoted to psoriatic arthritis this week, the two organizations said Monday.

October 7, 2013

A trade group of generic drug makers is hoping that California's governor vetoes a bill that it says would restrict patients' access to biosimilars.

October 7, 2013

Late-stage clinical data support the efficacy of an experimental drug under development by Teva Pharmaceutical Industries and Active Biotech for multiple sclerosis, the two companies said.

October 7, 2013

State representatives in Massachusetts have unanimously passed a bill that would allow patients to check the safety records of compounding pharmacies there, according to published reports.

October 3, 2013

The Food and Drug Administration is requiring Johnson & Johnson to use long-lasting ink in the labeling and dosage strength of an opioid painkiller patch it markets in order to make it easier to see.

October 2, 2013

Outcomes improve and there can be significant cost savings when infusion pharmacists monitor patients receiving home-based infusion services and intervene when dose adjustments are necessary, according to a Walgreens outcomes analysis study being presented Wednesday at IDWeek 2013 in San Francisco.

September 30, 2013

The Food and Drug Administration has approved a drug for treating early-stage breast cancer before surgery, the agency said Monday.

September 30, 2013

The Food and Drug Administration has approved a new usage for a drug made by UCB, the drug maker said Monday.

September 30, 2013

H. D. Smith on Monday announced full ownership acquisition of Triplefin, a reimbursement, patient assistance and pharmaceutical brand-support services company headquartered in Cincinnati.

September 27, 2013

A bill designed to strengthen the security of the drug supply chain by creating an electronic track-and-trace system and national standards for sterile pharmacy compounding has attracted support from trade groups representing independent pharmacies and generic drug makers.

September 27, 2013

The National Multiple Sclerosis Society is putting $7 million toward research into ways to speed repair of the nervous system in patients with MS, the organization said Friday.

September 26, 2013

A professional organization for specialty pharmacy plans to develop pharmacy practice parameters in about 20 therapeutic categories focused on disease management.

September 26, 2013

Legislation to allow the Food and Drug Administration to strengthen its regulatory powers over compounding pharmacies is expected to pass both houses of Congress after committees agreed on it Thursday, according to published reports.

September 25, 2013

A bill under consideration by the Senate could force more than 40% of compounding pharmacies to abandon compounding, according to a new survey.

September 25, 2013

Next year, 7 million people will be using health insurance marketplaces, and that figure will nearly quadruple in five years, according to a coalition of cancer-focused organizations.

September 24, 2013

Belgian drug maker Ablynx is licensing an experimental treatment for rheumatoid arthritis and lupus to U.S. drug maker AbbVie in a deal worth up to $840 million.

September 24, 2013

The Food and Drug Administration has approved a new dosage strength for a chronic pain patch made by Purdue Pharma, the drug maker said Tuesday.

September 24, 2013

A decision by the Department of Health and Human Services to resolve conflicts that arose when it issued regulations under a law that establishes privacy rules for health information technology has drawn applause from a specialty pharmacy organization.

September 23, 2013

The Food and Drug Administration has approved a drug made by Johnson & Johnson for psoriatic arthritis, the company said Monday.

September 23, 2013

Sandoz has launched an authorized generic drug for treating a disease commonly known as pre-leukemia, the company said on Monday.